Use CaseAccelerating Diversity Enrollment in a Phase III COVID-19 Trial - Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial

<p><span style="font-size:0.5em;">Use Case</span><br><span class="color-class-mint" style="font-size:1.0em;">Accelerating Diversity</span> Enrollment in a Phase III COVID-19 Trial</p><p>Citeline Connect Helps Sponsor Reach Diversity & Inclusion Goals</p>With the eyes of the world upon on them, a biotechnology company’s COVID-19 Phase III clinical trial inched closer to its target enrollment of 30,000 participants but was not meeting one milestone: inclusion of participants from communities that...Contents

<p>A Recruiting Challenge for One of the Most Pivotal Clinical Trials of  Our Lifetime</p>

<p>Citeline Connect <br>to the Rescue</p>

<p>Setting Up Sites <br>for Success</p>

<p>Randomizations <br>Over Time</p>

<p>Citeline Connect Delivers 20% of Randomizations</p>

<p>Recruitment Funnel (Sept. 17 – Oct. 19)</p>

Recruitment Partner Perspective

<p>Connect. Refer. <br>Screen. Enroll</p>

Thank you for reading <p><span style="font-size:0.9em;">Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial</span></p>